Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2000582	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products	Supplementary Application	2020-11-28	武田药品（中国）有限公司	Takeda Pharmaceutical (China) Company LIMITED	Certificate Issued	2021-09-07	view
JXSS2000018	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products	Import Drug Application	2020-07-04	武田药品（中国）有限公司	Takeda Pharmaceutical (China) Company LIMITED	In Review	2020-07-03	view
JXSS1900015	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products	Import Drug Application	2019-04-28	武田药品（中国）有限公司	Takeda Pharmaceutical (China) Company LIMITED	Certificate Issued	2020-05-14	view
JXSL2000008	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products	Import Drug Application	2020-01-23	武田药品（中国）有限公司	Takeda Pharmaceutical (China) Company LIMITED	In Review	2020-01-22	view
JXSL1300037	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products	Import Drug Application	2013-06-07	武田药品（中国）有限公司	Takeda Pharmaceutical (China) Company LIMITED	Certificate Issued	2016-03-08	view
JXSL1300033	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products	Import Drug Application	2013-05-20	武田药品（中国）有限公司	Takeda Pharmaceutical (China) Company LIMITED	Certificate Issued	2016-02-03	view
JYSB1400101	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products	Supplementary Application	2014-10-16	武田药品（中国）有限公司	Takeda Pharmaceutical (China) Company LIMITED	Certificate Issued	2016-02-03	view
JYSB2300143	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products(3.1)	Supplementary Application	2023-08-19					view
JYSB2300092	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products(3.1)	Supplementary Application	2023-05-13					view
JXSL2200028	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products(3.1)	Import Drug Application	2022-03-11					view
JYSZ2400054	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products(3.1)	License Renew	2024-10-16					view
JYSB2101109	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products	Supplementary Application	2021-08-23					view
JYSB2300163	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products(3.1)	Supplementary Application	2023-09-16					view
JYSB2300153	注射用维布妥昔单抗	brentuximab vedotin	Lyophilized	Biological Products(3.1)	Supplementary Application	2023-09-09					view